We have seen a noticeable increase in life sciences organisations’ desire to leverage IT services – this is part of a broader trend that is played out across the industry in areas like the application of AI and machine learning to pharma companies’ drug discovery processes.
Our Commercial Technology team has been working on a range of IT and outsourcing deals for life sciences customers, and our Regulatory team has been advising on the regulatory issues of using new and emerging technology. The main barriers to the increased adoption of IT and outsourcing services in the life sciences sector often revolve around misperceptions about the regulatory environment and how it makes use of services IT suppliers typically provide.
This article will explore the regulatory framework and how it might apply to such services, and set out our thoughts on how suppliers can use this awareness to gain a stronger foothold with life sciences customers. Read the full article on our technology focused microsite The Cookie Jar.